Integrated Core Strategies (Asia) Pte. Ltd. 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-10 4:22 pm Purchase | 2025-11-04 | 13G | KalVista Pharmaceuticals, Inc. KALV | Integrated Core Strategies (Asia) Pte. Ltd. | 2,531,010 5.000% | 2,531,010 (New Position) | Filing |